DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-1.67%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.11B
AUM Growth
+$5.11B
(-9.2%)
Cap. Flow
+$49.9M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
36.57%
Holding
172
New
27
Increased
20
Reduced
18
Closed
38
Top Buys
| 1 |
Nuvalent
NUVL
|
$436M |
| 2 |
GeneDx Holdings
WGS
|
$105M |
| 3 |
Neurocrine Biosciences
NBIX
|
$40M |
| 4 |
Glaukos
GKOS
|
$29.8M |
| 5 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$24.5M |
Top Sells
| 1 |
Zimmer Biomet
ZBH
|
$54.4M |
| 2 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$54.1M |
| 3 |
QuidelOrtho
QDEL
|
$52.4M |
| 4 |
Galapagos
GLPG
|
$45.3M |
| 5 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$42.5M |
Sector Composition
| 1 | Healthcare | 66.55% |
| 2 | Financials | 1.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Nuvalent
NUVL
$5.52B
| $436M | 8.51% | +19,341,024 | New | +$436M |
|
2
Viatris
VTRS
$12.3B
| $255M | 4.98% | 18,824,000 | – | – |
|
3
AdaptHealth
AHCO
$1.28B
| $189M | 3.68% | 8,103,792 +750,000 | +10% | +$17.5M |
|
|
CMAX
4
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $162M | 3.16% | 16,778,750 | – | – |
|
|
5
Neurocrine Biosciences
NBIX
$13.8B
| $110M | 2.14% | 1,142,415 +417,415 | +58% | +$40M |
|
6
Organogenesis Holdings
ORGO
$653M
| $106M | 2.07% | 7,462,543 +240,416 | +3% | +$3.42M |
|
|
7
GeneDx Holdings
WGS
$3.72B
| $105M | 2.05% | +13,848,488 | New | +$105M |
|
|
OMIC
8
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $102M | 1.99% | 9,112,019 | – | – |
|
|
ISEE
9
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $79M | 1.54% | 4,863,725 -903,684 | -16% | -$14.7M |
|
10
Pulmonx
LUNG
$69.7M
| $73M | 1.43% | 2,029,887 +229,000 | +13% | +$8.24M |
|
11
Larimar Therapeutics
LRMR
$310M
| $67.2M | 1.31% | 5,830,249 | – | – |
|
12
Mirum Pharmaceuticals
MIRM
$3.71B
| $65.4M | 1.28% | 3,282,912 -166,000 | -5% | -$3.31M |
|
13
Edgewise Therapeutics
EWTX
$1.51B
| $65.3M | 1.27% | 3,933,137 | – | – |
|
14
Molina Healthcare
MOH
$9.8B
| $62.9M | 1.23% | 231,776 | – | – |
|
15
Centene
CNC
$14.3B
| $62.5M | 1.22% | 1,003,800 +8,800 | +0.9% | +$548K |
|
16
Cytokinetics
CYTK
$4.23B
| $54.9M | 1.07% | 1,536,758 +298,675 | +24% | +$10.7M |
|
|
SILK
17
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $54.5M | 1.06% | 990,251 -148,274 | -13% | -$8.16M |
|
18
Pacira BioSciences
PCRX
$1.2B
| $54.2M | 1.06% | 967,236 -179,764 | -16% | -$10.1M |
|
|
APR
19
DELISTED
Apria, Inc. Common Stock
APR
| $52.7M | 1.03% | 1,417,700 -155,192 | -10% | -$5.77M |
|
20
The Oncology Institute
TOI
$318M
| $49.7M | 0.97% | 5,000,000 | – | – |
|
21
Alphatec Holdings
ATEC
$2.35B
| $43.8M | 0.86% | 3,594,829 +192,445 | +6% | +$2.35M |
|
22
Kura Oncology
KURA
$686M
| $43.4M | 0.85% | 2,315,417 +521,417 | +29% | +$9.77M |
|
23
Revolution Medicines
RVMD
$7.1B
| $43.1M | 0.84% | 1,565,712 | – | – |
|
24
Day One Biopharmaceuticals
DAWN
$769M
| $40.6M | 0.79% | 1,710,730 +891,750 | +109% | +$21.2M |
|
|
VIVO
25
DELISTED
Meridian Bioscience Inc
VIVO
| $39.7M | 0.77% | 2,063,083 +638,809 | +45% | +$12.3M |
|